Concepedia

Hind Ali Alkhatabi

HA

Statistics

Publications

5

Citations

138

H-Index

5

Active since

2022

Affiliations

University of Jeddah(Current)

King Abdulaziz University

Hamad Medical Corporation

Prince Sattam Bin Abdulaziz University

Shaqra University

Hind Ali Alkhatabi is an author at University of Jeddah specializing in tumor biology, drug resistance, and metabolic reprogramming.

ORCID

Top concepts

Publications per year

2022–2024

5

Publications

5

NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells

Mahmood Hassan Dalhat, Mohammed Razeeth Shait Mohammed, Hind Ali Alkhatabi et al. · Clinical and Translational Medicine · 2022 · 55 citations · Full text

Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations

Huma Rafiq, Junjian Hu, Mohammed Ageeli Hakami et al. · Scientific Reports · 2023 · 27 citations · Full text

Venetoclax-Resistant MV4-11 Leukemic Cells Activate PI3K/AKT Pathway for Metabolic Reprogramming and Redox Adaptation for Survival

Hind Ali Alkhatabi, Samir F. Zohny, Mohammed Razeeth Shait Mohammed et al. · Antioxidants · 2022 · 23 citations · Full text

, , +16

Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target

Amar Ajmal, Hind Ali Alkhatabi, Roaa M. Alreemi et al. · BMC Chemistry · 2024 · 19 citations · Full text

A comparative <i>in vitro</i> study on the effect of SGLT2 inhibitors on chemosensitivity to doxorubicin in MCF-7 breast cancer cells

Shahid Karim, Alanoud Alghanmi, Maha Jamal et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2024 · 14 citations · Full text

1–5 of 5